Key result
Preoperative PPI use is linked to ~43% higher 90-day mortality after femur fracture fixation.
Why the study?
The association between proton pump inhibitor use and postoperative outcomes following intermedullary nailing of intertrochanteric femur fractures and open reduction internal fixation of proximal humerus fractures required evaluation.
Does preoperative proton pump inhibitor use within 90 days of surgery increase the risk of 90-day and 2-year postoperative complications compared to non-use in adults undergoing intermedullary nailing for intertrochanteric femur fractures or open reduction internal fixation for proximal humerus fractures?
Cohort (n=27,438)
Yes
Does preoperative proton pump inhibitor use within 90 days of surgery increase the risk of 90-day and 2-year postoperative complications compared to non-use in adults undergoing intermedullary nailing for intertrochanteric femur fractures or open reduction internal fixation for proximal humerus fractures?
Preoperative proton pump inhibitor use within 90 days of orthopedic fracture fixation is associated with significantly increased risks of postoperative thromboembolic events, infections, myocardial infarction, acute kidney injury, mortality, and impaired fracture healing.
Answers are grounded in this paper and cite their sources.
Preoperative PPI use may warrant caution in fracture patients; leaves open causality versus confounding and requires prospective trials before practice change.
Purpose: To evaluate the association between proton pump inhibitor (PPI) and postoperative outcomes following intermedullary nailing (IMN) of intertrochanteric femur fractures and open reduction internal fixation (ORIF) of proximal humerus fractures. Methods: Two parallel retrospective cohort analyses were performed using the TriNetX Research Network. Adults (>18 y/o) undergoing IMN for intertrochanteric fractures (n=10,605 per cohort) or ORIF for proximal humerus fractures (n=3,114 per cohort) were grouped by PPI use within 90 days preoperatively. Propensity score matching balanced demographic and clinical characteristics. Outcomes were assessed within 90 days and 2 years postoperatively, reported as risk ratios (RR) with significance as p<0.05. Results: After IMN, PPI use was associated with an increased risk of pulmonary embolism (RR:1.4, p=0.014), acute kidney injury (RR:1.3, p=0.001), and myocardial infarction (RR:1.3, p=0.033 at 90-days follow-up. At 2-years, PPI use was linked to higher rates of deep vein thrombosis (RR:1.1, p=0.031), acute kidney injury (RR:1.2, p=0.006), and pneumonia (RR:1.1, p=0.010). After ORIF, PPI use within 90 days postoperatively was associated with wound disruption (RR:1.7, p=0.05), infection (RR:1.8, p=0.002), deep vein thrombosis (RR:1.8, p=0.026), and pulmonary embolism (RR:2.8, p=0.003). At the 2-years, PPI users experienced increased risks of infection (RR:1.5, p=0.003), DVT (RR:1.8, p=0.002), PE (RR:1.8, p=0.019), UTI (RR:1.3, p=0.022), nonunion (RR:1.7, p=0.004), and malunion (RR:2.1, p=0.025). Conclusion: PPI use is associated with adverse postoperative outcomes following IMN of intertrochanteric fractures and ORIF for proximal humerus fractures. Prospective studies are needed to clarify the causal relationships and isolate the effect of PPI use on postoperative outcomes.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) conducted a cohort in Intertrochanteric femur fractures treated with intramedullary nailing and proximal humerus fractures treated with open reduction internal fixation (n=27,438). Preoperative proton pump inhibitor (PPI) use within 90 days prior to surgery vs. No proton pump inhibitor use within 90 days prior to surgery was evaluated on 90-day postoperative all-cause mortality following intramedullary nailing for intertrochanteric femur fracture (RR 1.43, 95% CI 1.30-1.59, p=<0.001). Preoperative proton pump inhibitor use increased 90-day all-cause mortality after intertrochanteric femur fracture fixation and proximal humerus ORIF.
Synapse has enriched 10 related papers. Consider them for comparative context: